Uveal Melanoma and Brachytheraphy: Long-term Outcomes.
This study investigated the visual and anatomical outcomes, tumor control, tumor recurrence, distant metastasis and cancer free survival in patients affected by uveal melanoma and undergoing Ru-106 plaque brachytherapy between February 2011 and March 2020
106 Ruthenium Plaque Brachytherapy|Uveal Melanoma
RADIATION: 106 Ruthenium plaque brachytherapy
To evaluate long-term outcomes in patients underwent brachytherapy for uveal melanoma, To investigate the visual and anatomical outcomes, tumor control, tumor recurrence, distant metastasis and cancer free survival, Mean follow-up was 4 years (3 months-9 years)
This study investigated the visual and anatomical outcomes, tumor control, tumor recurrence, distant metastasis and cancer free survival in patients affected by uveal melanoma and undergoing Ru-106 plaque brachytherapy between February 2011 and March 2020